Russell Investments Group
GBT

Russell Investments Group’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Russell Investments Group’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-42,375
Closed -$1.24M – 3012
2021
Q4 		$1.24M Sell
42,375
-12,623
-23% -$391K ﹤0.01% 2043
2021
Q3 		$1.4M Buy
54,998
+24,287
+79% +$714K ﹤0.01% 2031
2021
Q2 		$1.07M Sell
30,711
-2,883
-9% -$113K ﹤0.01% 2278
2021
Q1 		$1.37M Sell
33,594
-12,066
-26% -$555K ﹤0.01% 2101
2020
Q4 		$1.98M Buy
+45,660
New +$2.25M ﹤0.01% 1764
2020
Q3 		– Sell
-30,434
Closed -$1.92M – 3287
2020
Q2 		$1.92M Sell
30,434
-41,135
-57% -$2.82M ﹤0.01% 1665
2020
Q1 		$3.65M Buy
71,569
+15,909
+29% +$1.07M 0.01% 1123
2019
Q4 		$4.42M Buy
55,660
+20,996
+61% +$1.24M 0.01% 1293
2019
Q3 		$1.68M Buy
34,664
+141
+0.4% +$7.35K ﹤0.01% 1768
2019
Q2 		$1.82M Sell
34,523
-1,721
-5% -$98.9K ﹤0.01% 1724
2019
Q1 		$1.92M Buy
36,244
+3,220
+10% +$158K ﹤0.01% 1740
2018
Q4 		$1.36M Sell
33,024
-7,010
-18% -$263K ﹤0.01% 1787
2018
Q3 		$1.52M Buy
40,034
+15,037
+60% +$666K ﹤0.01% 1895
2018
Q2 		$1.13M Hold
24,997
– – ﹤0.01% 2053
2018
Q1 		$1.21M Sell
24,997
-6,506
-21% -$363K ﹤0.01% 2120
2017
Q4 		$1.28M Sell
31,503
-26,375
-46% -$985K ﹤0.01% 2027
2017
Q3 		$1.8M Buy
57,878
+13,864
+31% +$390K ﹤0.01% 1847
2017
Q2 		$1.2M Buy
44,014
+15,253
+53% +$454K ﹤0.01% 2015
2017
Q1 		$1.06M Buy
28,761
+26,270
+1,055% +$662K ﹤0.01% 2066
2016
Q4 		$35K Buy
+2,491
New +$43.8K ﹤0.01% 3006

Other funds holding GBT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Russell Investments Group's GBT Position: Q1 2022 in Review

Russell Investments Group sold out of Global Blood Therapeutics, Inc. (GBT) in Q1 2022, closing a stake of 42,375 shares — an estimated $1.24M sold.

Russell Investments Group first reported a position in GBT in Q4 2016 and held it in 20 quarters. The position peaked at $4.42M in Q4 2019. 204 funds tracked by Wall St. Rank hold GBT as of Q1 2022.

  • Russell Investments Group reported no remaining Global Blood Therapeutics, Inc. position as of Q1 2022 after selling out during the quarter.
  • Russell Investments Group sold 42,375 Global Blood Therapeutics, Inc. shares in Q1 2022, an estimated $1.24M.
  • Russell Investments Group first reported a position in Global Blood Therapeutics, Inc. in Q4 2016 and held it in 20 quarters.
  • Russell Investments Group's Global Blood Therapeutics, Inc. position peaked at $4.42M in Q4 2019.
  • 204 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q1 2022.

Based on Russell Investments Group's 13F filing for Q1 2022, filed 5 May 2022.